Should we expect neurological symptoms in the SARS-CoV-2 epidemic?

¿Es esperable que haya cuadros neurológicos por la pandemia por SARS-CoV-2?
Central nervous system Coronavirus Esclerosis múltiple MERS-CoV Mouse hepatitis virus Multiple sclerosis Neurological symptoms SARS-CoV SARS-CoV-2 Sistema nervioso central Síntomas neurológicos Virus murino de la hepatitis

Journal

Neurologia
ISSN: 2173-5808
Titre abrégé: Neurologia (Engl Ed)
Pays: Spain
ID NLM: 101778590

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 27 03 2020
accepted: 31 03 2020
pubmed: 18 4 2020
medline: 6 5 2020
entrez: 18 4 2020
Statut: ppublish

Résumé

There is growing evidence that SARS-CoV-2 can gain access to the central nervous system (CNS). We revise the literature on coronavirus infection of the CNS associated with neurological diseases. Neurological symptoms were rarely reported in the SARS-CoV and MERS-CoV epidemics, although isolated cases were described. There are also reports of cases of neurological symptoms associated with CoV-OC43 and CoV-229E infection. The presence of neurological lesions, especially demyelinating lesions in the mouse hepatitis virus model, may explain the mechanisms by which coronaviruses enter the CNS, particularly those related with the immune response. This may explain the presence of coronavirus in patients with multiple sclerosis. We review the specific characteristics of SARS-CoV-2 and address the question of whether the high number of cases may be associated with greater CNS involvement. Although neurological symptoms are not frequent in coronavirus epidemics, the high number of patients with SARS-CoV-2 infection may explain the presence of the virus in the CNS and increase the likelihood of early- or delayed-onset neurological symptoms. Follow-up of patients affected by the SARS-CoV-2 epidemic should include careful assessment of the CNS.

Identifiants

pubmed: 32299636
pii: S0213-4853(20)30065-7
doi: 10.1016/j.nrl.2020.03.001
pmc: PMC7136883
pii:
doi:

Types de publication

Journal Article Review

Langues

eng spa

Sous-ensembles de citation

IM

Pagination

170-175

Informations de copyright

Copyright © 2020 Sociedad Española de Neurología. Publicado por Elsevier España, S.L.U. All rights reserved.

Références

Emerg Infect Dis. 2004 Feb;10(2):342-4
pubmed: 15030709
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Front Cell Neurosci. 2018 Oct 26;12:386
pubmed: 30416428
Arch Neurol. 2004 Nov;61(11):1669-73
pubmed: 15534177
Arch Neurol. 2005 Jul;62(7):1113-7
pubmed: 16009768
Eur Rev Med Pharmacol Sci. 2020 Mar;24(5):2781-2783
pubmed: 32196628
J Virol. 1997 Jan;71(1):800-6
pubmed: 8985420
Hum Vaccin Immunother. 2019;15(2):496-502
pubmed: 30235060
Chin Med J (Engl). 2020 May 5;133(9):1025-1031
pubmed: 32044814
J Virol. 1999 Apr;73(4):3326-37
pubmed: 10074187
J Infect Dis. 2013 Jun 1;207(11):1743-52
pubmed: 23532101
J Med Virol. 2020 Jun;92(6):552-555
pubmed: 32104915
Acta Neuropathol. 2001 Jun;101(6):601-4
pubmed: 11515789
Case Rep Neurol Med. 2016;2016:3502683
pubmed: 27239356
J Virol. 1999 Apr;73(4):3338-50
pubmed: 10074188
Adv Exp Med Biol. 1998;440:635-9
pubmed: 9782339
Virology. 2009 Dec 20;395(2):255-67
pubmed: 19846189
Virology. 1992 Nov;191(1):502-5
pubmed: 1413524
Emerg Microbes Infect. 2020 Dec;9(1):221-236
pubmed: 31987001
Neurology. 2003 Dec 23;61(12):1820-1
pubmed: 14694063
J Neurol. 2004 Oct;251(10):1227-31
pubmed: 15503102
Mov Disord. 1992;7(2):153-8
pubmed: 1316552
J Neuroimmune Pharmacol. 2009 Jun;4(2):200-12
pubmed: 19016329
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
J Virol. 2000 Oct;74(19):8913-21
pubmed: 10982334
J Virol. 2015 Oct;89(19):9896-908
pubmed: 26202229
Crit Rev Immunol. 2010;30(2):119-30
pubmed: 20370625
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
Clin Infect Dis. 2020 Dec 3;71(9):2428-2446
pubmed: 32215622
BMJ. 2020 Feb 19;368:m606
pubmed: 32075786
Cureus. 2020 Mar 21;12(3):e7352
pubmed: 32328364
Virus Res. 2014 Dec 19;194:145-58
pubmed: 25281913
Adv Virus Res. 2018;100:163-188
pubmed: 29551135
J Virol. 2016 Dec 16;91(1):
pubmed: 27795420
Adv Exp Med Biol. 2014;807:75-96
pubmed: 24619619
Saudi Med J. 2017 Feb;38(2):196-200
pubmed: 28133694
Virus Res. 2015 Apr 16;202:89-100
pubmed: 25432065
ACS Chem Neurosci. 2020 Apr 1;11(7):995-998
pubmed: 32167747
Front Immunol. 2018 Dec 20;9:3022
pubmed: 30619363
Pediatrics. 2004 Jan;113(1 Pt 1):e73-6
pubmed: 14702500
J Gen Virol. 1995 Dec;76 ( Pt 12):3201-4
pubmed: 8847530
J Pediatr Neurosci. 2015 Jul-Sep;10(3):280-1
pubmed: 26557177
Ann Neurol. 1992 May;31(5):525-33
pubmed: 1596089
PLoS One. 2014 Oct 31;9(10):e111351
pubmed: 25360880
J Gen Virol. 1982 Jun;60(Pt 2):307-14
pubmed: 7108490
Arch Virol. 1992;122(1-2):35-44
pubmed: 1309644
Neurology. 1982 Mar;32(3):292-5
pubmed: 6278362
Microb Pathog. 1994 May;16(5):349-57
pubmed: 7815918
J Virol. 2018 Aug 16;92(17):
pubmed: 29925652
J Can Chiropr Assoc. 2011 Mar;55(1):32-9
pubmed: 21403780
Science. 1980 Aug 22;209(4459):933-4
pubmed: 7403860
Eur J Clin Microbiol Infect Dis. 2007 Feb;26(2):121-9
pubmed: 17219094
Curr Top Microbiol Immunol. 2001;253:247-71
pubmed: 11417138
Lab Invest. 1988 Jan;58(1):31-6
pubmed: 2826881
J Neurol Sci. 1976 May;28(1):121-6
pubmed: 932771
J Virol. 2012 Jan;86(1):81-93
pubmed: 22013052
SAGE Open Med Case Rep. 2019 Mar 21;7:2050313X19838750
pubmed: 30915222
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Int J Infect Dis. 2014 Dec;29:301-6
pubmed: 25303830
N Engl J Med. 2016 Aug 4;375(5):497-8
pubmed: 27518687
Infection. 2015 Aug;43(4):495-501
pubmed: 25600929
J Clin Neurol. 2017 Jul;13(3):227-233
pubmed: 28748673
Biochem Biophys Res Commun. 2004 Jul 9;319(4):1216-21
pubmed: 15194496
Lancet. 1985 Jun 8;1(8441):1313-5
pubmed: 2860501
Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):2162-2164
pubmed: 32141586
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Virology. 1984 Sep;137(2):347-57
pubmed: 6091333
Adv Exp Med Biol. 1987;218:287-95
pubmed: 2829542
PLoS Curr. 2013 Nov 12;5:
pubmed: 24270606
Virology. 2003 Oct 10;315(1):20-33
pubmed: 14592756
Nat Rev Immunol. 2011 May;11(5):318-29
pubmed: 21508982
Emerg Microbes Infect. 2020 Dec;9(1):386-389
pubmed: 32065057
J Neurol. 1993 Jul;240(7):417-22
pubmed: 8410082
Virology. 2006 Jun 5;349(2):335-46
pubmed: 16527322
J Neurovirol. 2005 Aug;11(4):395-402
pubmed: 16162482
Methods Mol Biol. 2015;1282:1-23
pubmed: 25720466
Acta Neurol Taiwan. 2005 Sep;14(3):113-9
pubmed: 16252612
Virology. 2007 Oct 25;367(2):367-74
pubmed: 17631932
Microbes Infect. 2020 Mar;22(2):69-71
pubmed: 32032682
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Clin Microbiol Rev. 2007 Jan;20(1):49-78
pubmed: 17223623
New Microbiol. 1997 Apr;20(2):105-14
pubmed: 9208420
Intervirology. 2016;59(3):163-169
pubmed: 28103598

Auteurs

J Matías-Guiu (J)

Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, San Carlos, IdISSC, Madrid, España. Electronic address: neurol.hcsc@salud.madrid.org.

U Gomez-Pinedo (U)

Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, San Carlos, IdISSC, Madrid, España.

P Montero-Escribano (P)

Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, San Carlos, IdISSC, Madrid, España.

P Gomez-Iglesias (P)

Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, San Carlos, IdISSC, Madrid, España.

J Porta-Etessam (J)

Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, San Carlos, IdISSC, Madrid, España.

J A Matias-Guiu (JA)

Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, San Carlos, IdISSC, Madrid, España.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH